CMS Entry id: 2709 | Channel: Blog landing page | Template: blog/index

Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

27 August 2020

Does the impact of high-altitude impair cognitive performance?

Alexander Friend shares the role CANTAB played in the research he conducted on cognitive impairment at high-altitude while at The University of Birmingham.

18 August 2020

Accuracy of automated scoring of verbal paired associates in a remote data collection context

At the virtual AAIC 2020 conference Dr Francesca Cormack shared her research, focusing on automatic speech recognition for verbal cognitive testing. 

29 July 2020

Successful delivery of CANTAB cognitive assessments across diverse health systems

At the virtual AAIC 2020 conference Dr Elizabeth Baker presented data on the successful delivery of CANTABTM assessments across diverse health systems and ages: 10 – 90 years old.

The study captures normative performance across the lifespan to support a cognitive screening tool for characterising a range of neuropsychological disorders in clinics across India.

23 July 2020

Validating digital assessments for real-world testing

The power of remote assessments is the flexibility in when and where they can be administered. However, with this increased flexibility comes a responsibility to collect data at a frequency that is meaningful but not burdensome for the patient. This article will cover how to navigate this tricky process and strike the balance. 

21 July 2020

Four ways to better understand fatigue

Despite the significance of fatigue for patients living with chronic health conditions, the disorder is often overlooked. Interested in the patient perspective, we asked how they experience and manage their conditions as well as what they are looking for in an ideal treatment. Read on for the key take-aways from our study. 

14 July 2020

Guidance for including elderly patients in clinical trials

Older adults shoulder a disproportionate burden of chronic diseases and consumption of prescription drugs. Nevertheless, older adults, especially those aged over 75 years, are chronically under-represented in clinical trials. In this two part series, Dr Kiri Granger explores the risks of under-presentation and outlines guidance for including older adults in clinical trials.

Read on for session two: key design considerations when including elderly patients in clinical trials, with a focus on cognitive assessment.